# Meritage Homes CORP: financial statements, quarterly

MTH · NYSE · CIK 833079 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mth.md) · [Financials](/companies/mth/financials.md) · [Filings](/companies/mth/filings.md) · [Insiders](/companies/mth/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mth/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [0.0](/filings/0000833079-24-000121.md) | [0.0 d](/filings/0000833079-26-000010.md) | [0.0](/filings/0000833079-25-000089.md) | [0.0](/filings/0000833079-25-000119.md) | [0.0](/filings/0000833079-25-000138.md) | [0.0 d](/filings/0000833079-26-000010.md) | [0.0](/filings/0000833079-26-000105.md) | [0.0](/filings/0000833079-26-000128.md) | [0.0](/filings/0000833079-25-000138.md) | [0.0 d](/filings/0000833079-26-000010.md) | [0.6](/filings/0000833079-26-000105.md) | [2.2](/filings/0000833079-26-000128.md) |
| Income tax | $m | [64.0](/filings/0000833079-24-000121.md) | [60.0 d](/filings/0000833079-26-000010.md) | [48.0](/filings/0000833079-25-000089.md) | [65.8](/filings/0000833079-25-000119.md) | [54.0](/filings/0000833079-25-000138.md) | [48.9 d](/filings/0000833079-26-000010.md) | [37.4](/filings/0000833079-26-000105.md) | [46.2](/filings/0000833079-26-000128.md) | [29.0](/filings/0000833079-25-000138.md) | [19.1 d](/filings/0000833079-26-000010.md) | [17.2](/filings/0000833079-26-000105.md) | [29.9](/filings/0000833079-26-000128.md) |
| Net income | $m | [222](/filings/0000833079-24-000121.md) | [199 d](/filings/0000833079-26-000010.md) | [186](/filings/0000833079-25-000138.md) | [232](/filings/0000833079-25-000138.md) | [196](/filings/0000833079-25-000138.md) | [173 d](/filings/0000833079-26-000010.md) | [123](/filings/0000833079-26-000128.md) | [147](/filings/0000833079-26-000128.md) | [99.3](/filings/0000833079-25-000138.md) | [84.0 d](/filings/0000833079-26-000010.md) | [55.3](/filings/0000833079-26-000128.md) | [90.6](/filings/0000833079-26-000128.md) |
| Diluted EPS | $ per share | [5.98](/filings/0000833079-24-000121.md) | not reported | [2.53](/filings/0000833079-25-000089.md) | [3.15](/filings/0000833079-25-000119.md) | [2.67](/filings/0000833079-25-000138.md) | not reported | [1.69](/filings/0000833079-26-000105.md) | [2.04](/filings/0000833079-26-000128.md) | [1.39](/filings/0000833079-25-000138.md) | not reported | [0.82](/filings/0000833079-26-000105.md) | [1.37](/filings/0000833079-26-000128.md) |
| Basic EPS | $ per share | [6.06](/filings/0000833079-24-000121.md) | not reported | [2.56](/filings/0000833079-25-000089.md) | [3.19](/filings/0000833079-25-000119.md) | [2.70](/filings/0000833079-25-000138.md) | not reported | [1.71](/filings/0000833079-26-000105.md) | [2.06](/filings/0000833079-26-000128.md) | [1.40](/filings/0000833079-25-000138.md) | not reported | [0.82](/filings/0000833079-26-000105.md) | [1.38](/filings/0000833079-26-000128.md) |

- Revenue: not reported
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,049](/filings/0000833079-23-000147.md) | [921](/filings/0000833079-25-000021.md) | [905](/filings/0000833079-24-000079.md) | [993](/filings/0000833079-24-000092.md) | [832](/filings/0000833079-24-000121.md) | [652](/filings/0000833079-26-000010.md) | [1,012](/filings/0000833079-25-000089.md) | [930](/filings/0000833079-25-000119.md) | [729](/filings/0000833079-25-000138.md) | [775](/filings/0000833079-26-000128.md) | [767](/filings/0000833079-26-000105.md) | [807](/filings/0000833079-26-000128.md) |
| Total assets | $m | [6,182](/filings/0000833079-23-000147.md) | [6,353](/filings/0000833079-25-000021.md) | [6,489](/filings/0000833079-24-000079.md) | [6,924](/filings/0000833079-24-000092.md) | [7,103](/filings/0000833079-24-000121.md) | [7,163](/filings/0000833079-26-000010.md) | [7,700](/filings/0000833079-25-000089.md) | [7,756](/filings/0000833079-25-000119.md) | [7,759](/filings/0000833079-25-000138.md) | [7,622](/filings/0000833079-26-000128.md) | [7,555](/filings/0000833079-26-000105.md) | [7,555](/filings/0000833079-26-000128.md) |
| Total liabilities | $m | [1,761](/filings/0000833079-23-000147.md) | [1,741](/filings/0000833079-25-000021.md) | [1,769](/filings/0000833079-24-000079.md) | [2,041](/filings/0000833079-24-000092.md) | [2,074](/filings/0000833079-24-000121.md) | [2,021](/filings/0000833079-26-000010.md) | [2,505](/filings/0000833079-25-000089.md) | [2,487](/filings/0000833079-25-000119.md) | [2,471](/filings/0000833079-25-000138.md) | [2,427](/filings/0000833079-26-000128.md) | [2,461](/filings/0000833079-26-000105.md) | [2,497](/filings/0000833079-26-000128.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [4,421](/filings/0000833079-24-000121.md) | [4,612](/filings/0000833079-26-000010.md) | [4,721](/filings/0000833079-25-000138.md) | [4,883](/filings/0000833079-25-000138.md) | [5,030](/filings/0000833079-25-000138.md) | [5,142](/filings/0000833079-26-000128.md) | [5,195](/filings/0000833079-26-000128.md) | [5,269](/filings/0000833079-26-000128.md) | [5,288](/filings/0000833079-25-000138.md) | [5,196](/filings/0000833079-26-000128.md) | [5,094](/filings/0000833079-26-000128.md) | [5,058](/filings/0000833079-26-000128.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [104 d](/filings/0000833079-24-000121.md) | [(105) d](/filings/0000833079-26-000010.md) | [81.9](/filings/0000833079-25-000089.md) | [(118) d](/filings/0000833079-25-000119.md) | [(92.0) d](/filings/0000833079-25-000138.md) | [(99.6) d](/filings/0000833079-26-000010.md) | [(42.6)](/filings/0000833079-26-000105.md) | [13.7 d](/filings/0000833079-26-000128.md) | [(96.5) d](/filings/0000833079-25-000138.md) | [244 d](/filings/0000833079-26-000010.md) | [101](/filings/0000833079-26-000105.md) | [189 d](/filings/0000833079-26-000128.md) |
| Capital expenditure | $m | [10.1 d](/filings/0000833079-24-000121.md) | [7.0 d](/filings/0000833079-26-000010.md) | [6.3](/filings/0000833079-25-000089.md) | [6.9 d](/filings/0000833079-25-000119.md) | [8.0 d](/filings/0000833079-25-000138.md) | [7.5 d](/filings/0000833079-26-000010.md) | [5.6](/filings/0000833079-26-000105.md) | [6.8 d](/filings/0000833079-26-000128.md) | [7.8 d](/filings/0000833079-25-000138.md) | [5.6 d](/filings/0000833079-26-000010.md) | [4.3](/filings/0000833079-26-000105.md) | [5.6 d](/filings/0000833079-26-000128.md) |
| Dividends paid | $m | [9.8 d](/filings/0000833079-24-000121.md) | [9.8 d](/filings/0000833079-26-000010.md) | [27.2](/filings/0000833079-25-000089.md) | [27.2 d](/filings/0000833079-25-000119.md) | [27.1 d](/filings/0000833079-25-000138.md) | [27.0 d](/filings/0000833079-26-000010.md) | [30.9](/filings/0000833079-26-000105.md) | [30.6 d](/filings/0000833079-26-000128.md) | [30.3 d](/filings/0000833079-25-000138.md) | [29.3 d](/filings/0000833079-26-000010.md) | [32.0](/filings/0000833079-26-000105.md) | [31.3 d](/filings/0000833079-26-000128.md) |
| Share repurchases | $m | [45.0 d](/filings/0000833079-24-000121.md) | [4.1 d](/filings/0000833079-26-000010.md) | [55.9](/filings/0000833079-25-000089.md) | [0.0 d](/filings/0000833079-25-000119.md) | [30.0 d](/filings/0000833079-25-000138.md) | [40.0 d](/filings/0000833079-26-000010.md) | [45.0](/filings/0000833079-26-000105.md) | [45.0 d](/filings/0000833079-26-000128.md) | [55.0 d](/filings/0000833079-25-000138.md) | [150 d](/filings/0000833079-26-000010.md) | [130](/filings/0000833079-26-000105.md) | [100 d](/filings/0000833079-26-000128.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [36.9](/filings/0000833079-23-000147.md) | [37.1](/filings/0000833079-24-000079.md) | [37.2](/filings/0000833079-24-000092.md) | [37.1](/filings/0000833079-24-000121.md) | [73.6](/filings/0000833079-25-000089.md) | [73.4](/filings/0000833079-25-000119.md) | [73.3](/filings/0000833079-25-000138.md) | [72.7](/filings/0000833079-26-000105.md) | [71.9](/filings/0000833079-26-000128.md) | [71.2](/filings/0000833079-25-000138.md) | [67.8](/filings/0000833079-26-000105.md) | [66.1](/filings/0000833079-26-000128.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 65,174,093 at 2026-07-27, from the cover of the [10-Q filed 2026-07-31](/filings/0000833079-26-000128.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.